Evaluation of six-month clinical outcomes of patients with venous thromboembolism treated with apixaban, rivaroxaban, edoxaban or dabigatran
Cardiovascular Journal of Africa · 03.07.2026 · 37 (3) · 253-258
DOI: 10.5830/cvja-2026-015 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cardiovascular Journal of Africa, online erschienen am 03.07.2026. Verfasst von Abdulkadir Yilmaz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ankara Bilkent City Hospital, Department of Cardiovascular Surgery, Ankara, Turkey. Hauptthemen laut MEDLINE: Rivaroxaban, Dabigatran, Thiazoles, Factor Xa Inhibitors.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ankara Bilkent City Hospital, Department of Cardiovascular Surgery, Ankara, Turkey.
- Yıldırım Beyazıt University Faculty of Medicine, Department of Cardiovascular Surgery, Ankara, Turkey.
- Ankara Bilkent City Hospital, Department of Cardiovascular Surgery, Ankara, Turkey. Email: enisburakgul@gmail.com.
Zitieren
APA
Yilmaz, A., Sert, D. E., Kocabeyoglu, S. S., Uguz, E., Gül, E. B., Akkaya, B. B., Kervan, U., & Catav, Z. (2026). Evaluation of six-month clinical outcomes of patients with venous thromboembolism treated with apixaban, rivaroxaban, edoxaban or dabigatran. Cardiovascular Journal of Africa, 37(3), 253-258. https://doi.org/10.5830/cvja-2026-015
Vancouver
Yilmaz A, Sert DE, Kocabeyoglu SS, Uguz E, Gül EB, Akkaya BB, et al. Evaluation of six-month clinical outcomes of patients with venous thromboembolism treated with apixaban, rivaroxaban, edoxaban or dabigatran. Cardiovascular Journal of Africa. 2026;37(3):253-258. doi:10.5830/cvja-2026-015
BibTeX
@article{Yilmaz2026,
author = {Yilmaz, Abdulkadir and Sert, Dogan Emre and Kocabeyoglu, Sinan Sabit and Uguz, Emrah and Gül, Enis Burak and Akkaya, Bekir Boğaçhan and Kervan, Umit and Catav, Zeki},
title = {Evaluation of six-month clinical outcomes of patients with venous thromboembolism treated with apixaban, rivaroxaban, edoxaban or dabigatran},
journal = {Cardiovascular Journal of Africa},
year = {2026},
volume = {37},
number = {3},
pages = {253--258},
doi = {10.5830/cvja-2026-015}
}
EUVIMED